Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity

Journal of Neuro-Oncology

Volumn 102, Issue 2, 2011, Pages 225-235

  Enloe, Brian M ^a   Jay, Daniel G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Glioblastoma; Integrin linked kinase; Matrix metalloproteinase 2; Necl 5; Vitronectin

Indexed keywords

GELATINASE A; INTEGRIN LINKED KINASE; PROTEIN KINASE B; PROTEIN NECL 5; UNCLASSIFIED DRUG; VITRONECTIN; VITRONECTIN RECEPTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA INTERFERENCE;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL MEMBRANE; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; GLIOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 79953711715     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0323-5     Document Type: Article

References (49)

1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683-2710 (Pubitemid 350070717)
2. Nakada M, Nakada S, Demuth T, Tran NL, Hoelzinger DB, Berens ME (2007) Molecular targets of glioma invasion. Cell Mol Life Sci 64:458-478
3. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, Simeone M, Roy JE, Unger C, Louis DN, Ilag LL, Jay DG (2004) CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 4:73
4. Sloan KE, Stewart JK, Treloar AF, Matthews RT, Jay DG (2005) CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics. Cancer Res 65:10930-10937 (Pubitemid 41713361)
5. Takai Y, Miyoshi J, Ikeda W, Ogita H (2008) Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 9:603-615 (Pubitemid 352032927)
6. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E (2000) Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci USA 97:6803-6808 (Pubitemid 30412795)
7. Textor S, Durst M, Jansen L, Accardi R, Tommasino M, Trunk MJ, Porgador A, Watzl C, Gissmann L, Cerwenka A (2008) Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer 123:2343-2353
8. Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, Lustenberger P, Denis MG (2001) Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49:236-240 (Pubitemid 32675118)
9. Erickson BM, Thompson NL, Hixson DC (2006) Tightly regulated induction of the adhesion molecule Necl-5/CD155 during rat liver regeneration and acute liver injury. Hepatology 43:325-334
10. Ogita H, Ikeda W, Takai Y (2008) Roles of cell adhesion molecules nectin and nectin-like molecule-5 in the regulation of cell movement and proliferation. J Microsc 231:455-465
11. Giese A, Westphal M (1996) Glioma invasion in the central nervous system. Neurosurgery 39:235-250 (discussion 232-250)
12. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL (1999) Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 5:1587-1594 (Pubitemid 29282968)
13. Bafetti LM, Young TN, Itoh Y, Stack MS (1998) Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem 273:143-149 (Pubitemid 28042187)
14. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y (1999) Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 154:417-428 (Pubitemid 29094092)
15. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 14:35-42 (Pubitemid 26009753)
16. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G, Edwards DR (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79:1828-1835 (Pubitemid 29132312)
17. Price A, Shi Q, Morris D, Wilcox ME, Brasher PM, Rewcastle NB, Shalinsky D, Zou H, Appelt K, Johnston RN, Yong VW, Edwards D, Forsyth P (1999) Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Clin Cancer Res 5:845-854 (Pubitemid 29180837)
18. Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH, Roosen K (1999) Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 80:764-772 (Pubitemid 29066291)
19. Noha M, Yoshida D, Watanabe K, Teramoto A (2000) Suppression of cell invasion on human malignant glioma cell lines by a novel matrix- metalloproteinase inhibitor SI-27: in vitro study. J Neurooncol 48:217-223
20. McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 13:534-540 (Pubitemid 32817010)
21. Del Duca D, Werbowetski T, Del Maestro RF (2004) Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67:295-303 (Pubitemid 39137360)
22. Wang M, Wang T, Liu S, Yoshida D, Teramoto A (2003) The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 20:65-72 (Pubitemid 38146273)
23. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y (1994) Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81:69-77 (Pubitemid 24195510)
24. Sarkar S, Yong VW (2009) Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix. J Neurooncol 91:157-164
25. Heimberger AB, Wang E, McGary EC, Hess KR, Henry VK, Shono T, Cohen Z, Gumin J, Sawaya R, Conrad CA, Lang FF (2005) Mechanisms of action of rapamycin in gliomas. Neurooncology 7:1-11 (Pubitemid 40310188)
26. Lee HC, Park IC, Park MJ, An S, Woo SH, Jin HO, Chung HY, Lee SJ, Gwak HS, Hong YJ, Yoo DH, Rhee CH, Hong SI (2005) Sulindac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2. J Cell Biochem 94:597-610
27. Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK (2005) Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 4:1681-1688 (Pubitemid 41685302)
28. Kubiatowski T, Jang T, Lachyankar MB, Salmonsen R, Nabi RR, Quesenberry PJ, Litofsky NS, Ross AH, Recht LD (2001) Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 95:480-488 (Pubitemid 32781501)
29. Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Grone HJ, Ganten TM, Sultmann H, Tuttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-Mende C, Martin-Villalba A (2008) Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13:235-248 (Pubitemid 351324880)
30. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248
31. Qiao M, Sheng S, Pardee AB (2008) Metastasis and AKT activation. Cell Cycle 7:2991-2996
32. McDonald PC, Fielding AB, Dedhar S (2008) Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 121:3121-3132
33. Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S (2005) Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 24:3596-3605 (Pubitemid 40756229)
34. Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN (2007) Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26:4084-4094 (Pubitemid 46920166)
35. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95:11211-11216 (Pubitemid 28450107)
36. Mi Z, Guo H, Wai PY, Gao C, Kuo PC (2006) Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Carcinogenesis 27:1134-1145 (Pubitemid 43985428)
37. Li Y, Yang J, Dai C, Wu C, Liu Y (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Investig 112:503-516 (Pubitemid 38056335)
38. Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184-196 (Pubitemid 44163047)
39. Minami Y, Ikeda W, Kajita M, Fujito T, Amano H, Tamaru Y, Kuramitsu K, Sakamoto Y, Monden M, Takai Y (2007) Necl-5/poliovirus receptor interacts in cis with integrin alphaVbeta3 and regulates its clustering and focal complex formation. J Biol Chem 282:18481-18496 (Pubitemid 47100242)
40. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M (1994) Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin Exp Metastasis 12:296-304 (Pubitemid 24257067)
41. Uhm JH, Dooley NP, Villemure JG, Yong VW (1996) Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 14:421-433 (Pubitemid 26365119)
42. Fukushima Y, Tamura M, Nakagawa H, Itoh K (2007) Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid. J Neurosurg 107:578-585 (Pubitemid 47451042)
43. Ria R, Vacca A, Ribatti D, Di Raimondo F, Merchionne F, Dammacco F (2002) Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. Haematologica 87:836-845
44. Endersby R, Baker SJ (2008) PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27:5416-5430
45. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK (2001) Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20:6669-6678 (Pubitemid 33026073)
46. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, Berens ME (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116:4409-4417 (Pubitemid 37369596)
47. Zhang D, Bar-Eli M, Meloche S, Brodt P (2004) Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J Biol Chem 279:19683-19690 (Pubitemid 38623405)
48. Zucker S, Cao J, Chen WT (2000) Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19:6642-6650 (Pubitemid 32197703)
49. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408 (Pubitemid 34164012)